位置:首页 > 蛋白库 > FADS2_BOVIN
FADS2_BOVIN
ID   FADS2_BOVIN             Reviewed;         444 AA.
AC   A4FV48;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 1.
DT   03-AUG-2022, entry version 91.
DE   RecName: Full=Acyl-CoA 6-desaturase;
DE            EC=1.14.19.3 {ECO:0000250|UniProtKB:O95864};
DE   AltName: Full=Delta(6) fatty acid desaturase;
DE            Short=D6D;
DE            Short=Delta(6) desaturase;
DE            Short=Delta-6 desaturase {ECO:0000250|UniProtKB:O95864};
DE   AltName: Full=Fatty acid desaturase 2 {ECO:0000250|UniProtKB:O95864};
GN   Name=FADS2;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Hereford; TISSUE=Hippocampus;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (SEP-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in the biosynthesis of highly unsaturated fatty
CC       acids (HUFA) from the essential polyunsaturated fatty acids (PUFA)
CC       linoleic acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3)
CC       precursors, acting as a fatty acyl-coenzyme A (CoA) desaturase that
CC       introduces a cis double bond at carbon 6 of the fatty acyl chain.
CC       Catalyzes the first and rate limiting step in this pathway which is the
CC       desaturation of LA (18:2n-6) and ALA (18:3n-3) into gamma-linoleate
CC       (GLA) (18:3n-6) and stearidonate (18:4n-3), respectively (By
CC       similarity). Subsequently, in the biosynthetic pathway of HUFA n-3
CC       series, it desaturates tetracosapentaenoate (24:5n-3) to
CC       tetracosahexaenoate (24:6n-3), which is then converted to
CC       docosahexaenoate (DHA)(22:6n-3), an important lipid for nervous system
CC       function (By similarity). It can also desaturate (11E)-octadecenoate
CC       (trans-vaccenoate, a metabolite in the biohydrogenation pathway of LA
CC       and the predominant trans fatty acid in cow milk) at carbon 6
CC       generating (6Z,11E)-octadecadienoate (By similarity). In addition to
CC       Delta-6 activity, this enzyme exhibits Delta-8 activity with slight
CC       biases toward n-3 fatty acyl-CoA substrates (By similarity).
CC       {ECO:0000250|UniProtKB:B8R1K0, ECO:0000250|UniProtKB:O95864,
CC       ECO:0000250|UniProtKB:Q9Z122}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + 2 Fe(II)-[cytochrome b5] + 2
CC         H(+) + O2 = (6Z,9Z,12Z)-octadecatrienoyl-CoA + 2 Fe(III)-[cytochrome
CC         b5] + 2 H2O; Xref=Rhea:RHEA:47140, Rhea:RHEA-COMP:10438, Rhea:RHEA-
CC         COMP:10439, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:57363,
CC         ChEBI:CHEBI:57383; EC=1.14.19.3;
CC         Evidence={ECO:0000250|UniProtKB:O95864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47141;
CC         Evidence={ECO:0000250|UniProtKB:O95864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z,15Z)-octadecatrienoyl-CoA + 2 Fe(II)-[cytochrome b5] +
CC         2 H(+) + O2 = (6Z,9Z,12Z,15Z)-octadecatetraenoyl-CoA + 2 Fe(III)-
CC         [cytochrome b5] + 2 H2O; Xref=Rhea:RHEA:47144, Rhea:RHEA-COMP:10438,
CC         Rhea:RHEA-COMP:10439, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:29033, ChEBI:CHEBI:29034,
CC         ChEBI:CHEBI:71489, ChEBI:CHEBI:74034; EC=1.14.19.3;
CC         Evidence={ECO:0000250|UniProtKB:O95864};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47145;
CC         Evidence={ECO:0000250|UniProtKB:O95864};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z,15Z,18Z,21Z)-tetracosapentaenoyl-CoA + 2 Fe(II)-
CC         [cytochrome b5] + 2 H(+) + O2 = (6Z,9Z,12Z,15Z,18Z,21Z)-
CC         tetracosahexaenoyl-CoA + 2 Fe(III)-[cytochrome b5] + 2 H2O;
CC         Xref=Rhea:RHEA:36999, Rhea:RHEA-COMP:10438, Rhea:RHEA-COMP:10439,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:74083,
CC         ChEBI:CHEBI:74086; Evidence={ECO:0000250|UniProtKB:Q9Z122};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37000;
CC         Evidence={ECO:0000250|UniProtKB:Q9Z122};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(11E)-octadecenoyl-CoA + 2 Fe(II)-[cytochrome b5] + 2 H(+) +
CC         O2 = (6Z,11E)-octadecadienoyl-CoA + 2 Fe(III)-[cytochrome b5] + 2
CC         H2O; Xref=Rhea:RHEA:46064, Rhea:RHEA-COMP:10438, Rhea:RHEA-
CC         COMP:10439, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:74296,
CC         ChEBI:CHEBI:85652; Evidence={ECO:0000250|UniProtKB:Q9Z122};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46065;
CC         Evidence={ECO:0000250|UniProtKB:Q9Z122};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(11Z,14Z)-eicosadienoyl-CoA + 2 Fe(II)-[cytochrome b5] + 2
CC         H(+) + O2 = (8Z,11Z,14Z)-eicosatrienoyl-CoA + 2 Fe(III)-[cytochrome
CC         b5] + 2 H2O; Xref=Rhea:RHEA:39567, Rhea:RHEA-COMP:10438, Rhea:RHEA-
CC         COMP:10439, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:74264,
CC         ChEBI:CHEBI:76410; Evidence={ECO:0000250|UniProtKB:B8R1K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39568;
CC         Evidence={ECO:0000250|UniProtKB:B8R1K0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(11Z,14Z,17Z)-eicosatrienoyl-CoA + 2 Fe(II)-[cytochrome b5] +
CC         2 H(+) + O2 = (8Z,11Z,14Z,17Z)-eicosatetraenoyl-CoA + 2 Fe(III)-
CC         [cytochrome b5] + 2 H2O; Xref=Rhea:RHEA:39571, Rhea:RHEA-COMP:10438,
CC         Rhea:RHEA-COMP:10439, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:29033, ChEBI:CHEBI:29034,
CC         ChEBI:CHEBI:74265, ChEBI:CHEBI:74328;
CC         Evidence={ECO:0000250|UniProtKB:B8R1K0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39572;
CC         Evidence={ECO:0000250|UniProtKB:B8R1K0};
CC   -!- PATHWAY: Lipid metabolism; polyunsaturated fatty acid biosynthesis.
CC       {ECO:0000250|UniProtKB:O95864}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- DOMAIN: The protein sequence includes a number of characteristic
CC       features of microsomal fatty acid desaturases including the three
CC       histidine boxes HXXXH, HXXHH, and QXXHH (these domains may contain the
CC       active site and/or be involved in metal ion binding), and the N-
CC       terminal cytochrome b5 domain containing the heme-binding motif, HPGG,
CC       similar to that of other fatty acid desaturases.
CC       {ECO:0000250|UniProtKB:O95864}.
CC   -!- SIMILARITY: Belongs to the fatty acid desaturase type 1 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC123735; AAI23736.1; -; mRNA.
DR   RefSeq; NP_001076913.1; NM_001083444.1.
DR   AlphaFoldDB; A4FV48; -.
DR   SMR; A4FV48; -.
DR   STRING; 9913.ENSBTAP00000020610; -.
DR   PaxDb; A4FV48; -.
DR   PRIDE; A4FV48; -.
DR   Ensembl; ENSBTAT00000020610; ENSBTAP00000020610; ENSBTAG00000015505.
DR   GeneID; 521822; -.
DR   KEGG; bta:521822; -.
DR   CTD; 9415; -.
DR   VEuPathDB; HostDB:ENSBTAG00000015505; -.
DR   VGNC; VGNC:28702; FADS2.
DR   eggNOG; KOG4232; Eukaryota.
DR   GeneTree; ENSGT00950000182990; -.
DR   HOGENOM; CLU_016265_0_1_1; -.
DR   InParanoid; A4FV48; -.
DR   OMA; QWWKNKH; -.
DR   OrthoDB; 1060606at2759; -.
DR   TreeFam; TF313604; -.
DR   Reactome; R-BTA-2046105; Linoleic acid (LA) metabolism.
DR   Reactome; R-BTA-2046106; alpha-linolenic acid (ALA) metabolism.
DR   UniPathway; UPA00658; -.
DR   Proteomes; UP000009136; Chromosome 29.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016213; F:linoleoyl-CoA desaturase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016717; F:oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water; IBA:GO_Central.
DR   GO; GO:0006629; P:lipid metabolic process; IBA:GO_Central.
DR   GO; GO:0006636; P:unsaturated fatty acid biosynthetic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.10.120.10; -; 1.
DR   InterPro; IPR001199; Cyt_B5-like_heme/steroid-bd.
DR   InterPro; IPR036400; Cyt_B5-like_heme/steroid_sf.
DR   InterPro; IPR005804; FA_desaturase_dom.
DR   InterPro; IPR012171; Fatty_acid_desaturase.
DR   PANTHER; PTHR19353; PTHR19353; 1.
DR   Pfam; PF00173; Cyt-b5; 1.
DR   Pfam; PF00487; FA_desaturase; 1.
DR   PIRSF; PIRSF015921; FA_sphinglp_des; 1.
DR   SMART; SM01117; Cyt-b5; 1.
DR   SUPFAM; SSF55856; SSF55856; 1.
DR   PROSITE; PS50255; CYTOCHROME_B5_2; 1.
PE   2: Evidence at transcript level;
KW   Electron transport; Endoplasmic reticulum; Fatty acid biosynthesis;
KW   Fatty acid metabolism; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   Oxidoreductase; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..444
FT                   /note="Acyl-CoA 6-desaturase"
FT                   /id="PRO_0000307100"
FT   TOPO_DOM        1..122
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        123..143
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        144..147
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        148..168
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        169..264
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        265..285
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        286..305
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        306..326
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        327..444
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          18..95
FT                   /note="Cytochrome b5 heme-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00279"
FT   MOTIF           180..184
FT                   /note="Histidine box-1"
FT   MOTIF           217..221
FT                   /note="Histidine box-2"
FT   MOTIF           382..386
FT                   /note="Histidine box-3"
SQ   SEQUENCE   444 AA;  52533 MW;  6D0C887C1365D4C3 CRC64;
     MGKGGNQDEG ATELEAPMPT FRWEEIQKHN LRTDKWLVID RKVYNITKWS SRHPGGQRVI
     GHYAGEDATD AFLAFHRNLD FVRKFMKPLL IGELAPEEPS QDRGKNSQIT EDFRALRKTA
     EDMNLFKSNQ LFFLLHLAHI IAMESIAWFT LFYFGNGWIP TIITAFVLAT SQAQAGWLQH
     DYGHLSVYKK SMWNHIVHKF VIGHLKGASA NWWNHRHFQH HAKPNIFHKD PDVNMLHVFV
     LGEWQPIEYG KKKLKYLPYN HQHEYFFLIG PPLLIPLYFQ YQIIMTMIVR KYWADLAWAI
     SYYTRFFITY IPFYGVLGSI LFLNFIRFLE SHWFVWVTQM NHIVMEIDRE PYRDWFSSQL
     AATCNVEQSF FNDWFSGHLN FQIEHHLFPT MPRHNLHKIA PLVRSLCAKH GIEYQEKPLL
     RALQDIIGSL RKSGQLWLDA YLHK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024